rs12191459 - LINC01013

Magnitude 4.5 · 1 study on file

Reported associations

  • Genome-Wide Association Study of Metachronous Colorectal Adenoma Risk among Participants in the Selenium Trial. - Nutrition and cancer (2022) · Trejo MJ, Batai K, Chen Y, Brezina S, Chow HS, Ellis N, Lance P, Hsu CH, Pogreba-Brown K, Bishop M, Gsur A, Jacobs ET · PubMed 35815403

    Genetic variants related to colorectal adenoma may help identify those who are at highest risk of colorectal cancer development or illuminate potential chemopreventive strategies. The purpose of this genome-wide association study was to identify genetic variants that are associated with risk of developing a metachronous colorectal adenoma among 1,215 study participants of European descent from the Selenium Trial. Associations of variants were assessed with logistic regression analyses and validated in an independent case-control study population of 1,491 participants from the Colorectal Cancer Study of Austria (CORSA). No statistically significant genome-wide associations between any variant and metachronous adenoma were identified after correction for multiple comparisons. However, an int


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Screening

  • enhanced adenoma surveillance intervals Moderate

    T allele associated with 2.64-fold increased risk for advanced metachronous adenoma

    discuss with gastroenterologist about colonoscopy interval